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Introduction: Transfusion of red blood cells (RBCs) and, in particular, older RBCs has been associated with increased
short-term mortality in critically ill patients. We evaluated the association between age of transfused RBCs and acute
kidney injury (AKI), hospital, and 90-day mortality in critically ill patients.
Methods: We conducted a prospective, observational, predefined sub-study within the FINNish Acute Kidney Injury
(FINNAKI) study. This study included all elective ICU admissions with expected ICU stay of more than 24 hours and
all emergency admissions from September to November 2011. To study the age of RBCs, we classified transfused
patients into quartiles according to the age of oldest transfused RBC unit in the ICU. AKI was defined according to
KDIGO (Kidney Disease: Improving Global Outcomes) criteria.
Results: Out of 1798 patients, 652 received at least one RBC unit. The median [interquartile range] age of the oldest
RBC unit transfused was 12 [11-13] days in the freshest quartile and 21 [17-27] days in the quartiles 2 to 4. On
logistic regression, RBC age was not associated with the development of KDIGO stage 3 AKI. Patients in the quartile
of freshest RBCs had lower crude hospital and 90-day mortality rates compared to those in the quartiles of older
blood. After adjustments, older RBC age was associated with significantly increased risk for hospital mortality. Age,
Simplified Acute Physiology Score II (SAPS II)-score without age points, maximum Sequental Organ Failure
Assessment (SOFA) score and the total number of transfused RBC units were independently associated with
90-day mortality.
Conclusions: The age of transfused RBC units was independently associated with hospital mortality but not with
90-day mortality or KDIGO stage 3 AKI. The number of transfused RBC units was an independent risk factor for
90-day mortality.Introduction
Critically ill patients are frequently transfused during
their stay in ICU. Around 40% (37 to 44%) of patients
receive at least one red blood cell (RBC)-unit transfu-
sion, the mean being 4.6 units per patient during their
ICU stay [1,2]. Patients receive transfusions early after
ICU admission. For example, 75% of transfused patients
receive their first RBC transfusion by day 3 [2]. In gen-
eral, liberal blood transfusion practice does not appear
beneficial in critically ill patients, with the possible* Correspondence: maija.kaukonen@monash.edu
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reproduction in any medium, provided the orexception of those patients with acute myocardial ische-
mia [3] or severe sepsis and septic shock [4,5].
RBC units undergo changes over time, including sev-
eral biochemical changes in both RBCs themselves and
within the preservative medium [6]. The presence of
this storage lesion in RBC units has raised concern for
the benefit and safety of RBC transfusions, especially if
older RBC units are used. A recent meta-analysis includ-
ing more than 400,000 patients concluded that in many
patient groups including critically ill, cardiac surgery,
trauma and pediatric patient populations, the use of
older stored blood is potentially associated with a signifi-
cantly increased risk of death [7]. The majority of the
studies in this meta-analysis, however, were retrospective
or observational. In addition, three small randomized,
controlled trials (RCTs) have shown inconclusive resultsral Ltd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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found that fresher blood (less than 7 days old) did not
reduce mortality or morbidity compared to standard-
of-care RBCs [11].
The observational studies included in the meta-
analysis of Wang et al. reported only short-term mortal-
ity (in-hospital, 7-, 28-, and 30-day) except for one study
in colorectal cancer patients [7]. The association of the
age of RBC transfusions with acute kidney injury (AKI)
has not been reported. Thus, the association of age of
RBCs with AKI or with long-term mortality in a general
ICU population has not been reported so far.
Accordingly, we conducted a prospective observational
study as a part of the FINNish Acute Kidney Injury
(FINNAKI) study in critically ill patients to evaluate the
possible association of the age of RBCs with AKI and with
hospital and 90-day mortality. FINNAKI was a prospective
study evaluating the incidence, risk factors and 90-day
mortality of AKI in unselected critically ill patients.
Materials and methods
Data
We conducted a predefined sub-study of the previously
published FINNAKI study [12]. FINNAKI was a pro-
spective, observational study comprising 2,901 critically
ill patients admitted to 17 Finnish ICUs between 1 September
2011 and 1 February 2012. The patient population of
this sub-study included all FINNAKI patients between 1
September 2011 and 30 November 2011.
The Ethics Committee of the Department of Surgery
in Helsinki University Hospital gave approval for this
study and the use of deferred consent. Signed, informed
consent was obtained from the patient or proxy as soon
as possible after ICU admission. If informed consent
could not be obtained, the Finnish National Institute of
Health and Welfare approved the data collection for
study purposes from deceased patients.
Study patients
The study inclusion criteria were: 1) all emergency ICU
admissions, and 2) all elective patients with an expected
ICU stay of >24 hours. The exclusion criteria were: 1)
age less than 18 years, 2) readmission after receiving
renal replacement therapy (RRT) during a previous ad-
mission, 3) elective ICU admission for less than 24 hours
if discharged alive, 4) chronic dialysis, 5) organ donation,
6) no permanent residency in Finland or insufficient lan-
guage skills, 7) transferred patients included in the study
in previous ICU, and 8) intermediate care patients.
Red blood cell products
In Finland, all RBC units are provided by the Finnish Red
Cross Blood Service. RBC products are prepared from
anticoagulated whole blood by the buffy coat method.After addition of saline-adenine-glucose-mannitol (SAGM)
solution RBCs are leukodepleted by filtration. RBC
products comply with European Union directives and
Council of Europe standard [13]. In RBC product qual-
ity control (n = 2,904, year 2011), the mean amount of
hemoglobin was 49.8 g/unit (CI 95% 40.6, 59.0 g/unit)
and the number of residual leukocytes 0.03 × 106/unit
(CI 95% 0.00, 0.13 × 106/unit). The shelf life of RBC
products is 35 days.
Data collection
The Finnish Intensive Care Consortium prospective
database (Tieto Ltd, Helsinki, Finland) served as the
source for routine ICU data. The study-specific expan-
sion of the database included study case report forms
and calculation of KDIGO (Kidney Disease: Improving
Global Outcomes) stage for each patient, continuously
based on every measured hourly urine output and
plasma creatinine. The daily case report forms were col-
lected from ICU admission to day 5 in the ICU. The
data collection consisted of AKI and AKI risk factors, in-
cluding severe sepsis, using the definition of the American
College of Chest Physicians/Society of Critical Care
Medicine (ACCP/SCCM) [14]. Each patient was in-
cluded into the study only once. For readmitted patients,
only the admission with the oldest RBCs transfused was
included in the analysis. Nine randomly chosen study
sites were monitored for the reliability of the data collec-
tion with a structured monitoring plan. The dates and
donation numbers of all RBC units transfused to study
patients during their ICU stay were obtained directly
from the participating ICUs. The Finnish Red Cross
Blood Services provided information on RBC product
details including donation and expiry dates. We obtained
data on 90-day mortality from the Finnish Population
Register Center.
Definitions
AKI was defined according to the KDIGO criteria [15].
Renal non-recovery was defined as dependence on RRT
at day 90 [16]. The quartiles of transfused patients were
defined by calculating the age of all RBCs transfused to
the patient. The oldest RBC unit was chosen as the
index unit to allocate the patient to the RBC age quar-
tiles [17]. The lowest quartile (Q1) denotes patients
with the freshest oldest RBC unit. Q2, Q3, and Q4 de-
note patients in the second, third and fourth quartiles,
respectively. Massive blood transfusion was defined as
transfusion of >10 RBC units in 24 hours.
Statistical analyses
Data are presented as the median and IQR or as
absolute number and percentage. We calculated 95%
CI for the outcomes. We compared groups using the
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Fisher exact test for categorical data. We studied factors
associated with KDIGO stage 3 AKI during the first 5
days of ICU admission, hospital mortality, and 90-day
mortality as dependent variables in separate logistic re-
gression models. Variables were selected for the reported
models using the enter method. Covariates included in
the model predicting KDIGO stage 3 AKI were: pre-ICU
hypovolemia, pre-ICU use of colloids, presence of chronic
kidney disease, simplified acute physiology score (SAPS) II
(without age and renal components, that is, urine output,
serum urea, potassium, HCO3), age, gender, RBC age
quartile prior to the highest KDIGO AKI stage and num-
ber of RBC units transfused prior to AKI. Patients with
KDIGO stage 3 AKI prior to RBC transfusion were ex-
cluded from this model. For patients without AKI, we in-
cluded RBC units transfused within 26 hours from ICU
admission, which corresponded to the median time of de-
velopment of the KDIGO stage 3 AKI. For the models
predicting hospital mortality, and separately for 90-dayTable 1 Patient characteristics in quartiles according to oldes
Q1 Q2
(n = 143) (n = 156)
Age, years 66 (58, 76) 66 (57, 75)
Male gender 82 (57.3%) 102 (65.4%)
Operative admission 80 (55.9%) 85 (54.5%)
Emergency admission, n/total 105/143 (73.4%) 114/153 (74
Emergency surgery <1 week 38 (26.6%) 42 (26.9%)
Cardiac or vascular surgery 44 (30.8%) 56 (35.9%)
Trauma 9 (6.3%) 6 (3.8%)
Severe sepsis 34 (23.8%) 50 (32.1%)
DIC 5/140 (3.5%) 12/151 (7.9%
Acute kidney injury 52 (36.4%) 78 (50.0%)
Renal replacement therapy 8 (5.6%) 28 (17.9%)
SAPS II score 35 (27, 44) 36 (30, 50)
Maximum SOFA score 8 (6, 10) 9 (6, 11)
Mechanical ventilaiton 110 (76.9%) 132 (84.6%)
Vasoactive use 111 (77.6%) 124 (79.5%)
Lactate, mmol/Lb 1.96 (1.20, 3.40) 2.80 (1.50, 3
Age of all RBCs, days 11 (9, 12) 14 (11, 15)
Maximum age of RBCs, days 12 (10, 13) 15 (14, 16)
Transfused units, n 2 (2, 4) 3 (2, 5)
RBC units over 14 days old, n 0 2 (1, 3)
Massive transfusion pre-ICUc 8 (5.6%) 9 (5.8%)
Admission hemoglobin, g/L d 100 (90, 112) 97 (88, 107)
Results are presented as median (IQR) or number (%). aData missing for 1 patient in
day, data missing for 11 patients in Q1 and Q2, in 12 patients in Q3, and 17 patient
ddata missing for 11 patients in Q1, 19 in Q2, 27 in Q3, 20 in Q4 (and 86 patients in
coagulopathy; SAPS II, simplified acute physiology score; SOFA, sequential organ faimortality, we generated a propensity score to balance be-
tween the patients’ probability of receiving older blood
(>14 days in Q2 to Q4) and included patients’ blood
groups, study sites, and the numbers of transfused units
in the scoring. To study associations with hospital and
90-day mortality, we used the enter method to add covari-
ates in logistic regression analysis. Covariates in these
models were: propensity to receive older blood, age, gender,
number of transfused RBC units, age quartiles of transfused
RBCs (Q2 to Q4 versus Q1) presence of AKI, severe sepsis,
acute physiology and chronic health evaluation (APACHE)
II diagnosis group, operative admission, emergency admis-
sion, disseminated intravascular coagulopathy (DIC), SAPS
II without age points, maximum sequential organ failure
assessment (SOFA) score during ICU stay and highest
lactate value. We also performed Cox regression analysis
of 90-day mortality with the same explanatory variables as
we had covariates in logistic regression analysis for the
hospital and 90-day mortality. In all analyses a P-value less
than 0.05 was considered statistically significant. Reportedt red blood cell (RBC) transfusion during the ICU stay
Q3 Q4 P-value
(n = 179) (n = 174)
65 (54, 74) 66 (55, 75) 0.686
114 (63.7%) 113 (64.9%)
92 (51.4%) 74 (42.5%) 0.067
.5%) 146/174 (83.9%) 149/172 (85.6%) 0.004
58 (32.45) 49 (28.2%) 0.369
41 (22.9%) 29 (16.7%) <0.001
16 (8.9%) 13 (7.5%) 0.303
69 (38.5%) 69 (39.7%) 0.011
) 13/170 (7.6%) 16/168 (9.5%) 0.239
69 (38.5%) 69 (39.7%) 0.029
34 (19.0%) 26 (14.9%) 0.004
40 (28, 55) 38 (31, 53) 0.050
9 (6, 11) 9 (6, 11)a 0.031
149 (83.2%) 132 (75.9%) 0.112
142 (79.3%) 130 (74.7%)a 0.751
.40) 2.40 (1.44, 4.60) 2.54 (1.50, 4.77) 0.009
17 (13, 20) 17 (12, 26) <0.001
21 (19, 22) 29 (27, 32) <0.001
3 (2, 6) 4 (2, 8) 0.001
2 (1, 4) 3 (2, 6) <0.001
7 (3.9%) 15 (8.6%) 0.312
97(88, 110)] 98 (85, 113) 0.544
Q4; bhighest lactate 24 h preceding ICU admission or on first ICU treatment
s in Q4 (and 40 patients in Q2 to Q4); ctransfusion >10 RBC units in 24 hours;
Q2-4); n, number; RBC, red blood cell; DIC, disseminated intravascular
lure assessment.
Table 2 Incidence of AKI according to KDIGO staging in
transfused patients according to quartiles of oldest red
blood cells transfused
Quartile 1 (n = 143) Quartiles 2 to 4 (n = 509) P-value
No AKI 63.6% (55.8, 71.5) 49.5% (45.2, 53.9) 0.003
Stage 1 19.6% (13.1, 26.1) 19.6% (16.2, 23.1) >0.999
Stage 2 5.6% (1.8, 9.4) 9.4% (6.9, 12.0) 0.177
Stage 3 11.2% (6.0, 16.4) 21.4% (17.9, 25.0) 0.006
RRT 5.6% (1.8, 9.4) 17.3% (14.0, 20.6) <0.001
Results are presented as percentage of patients (95% CI). AKI, acute kidney
injury; KDIGO, Kidney Disease: Improving Global Outcomes; RRT, renal
replacement therapy.
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Data were analyzed with SPSS version 19 (SPSS, Chicago,
IL, USA).
Results
Of the 1,811 eligible patients, 665 received at least one
RBC transfusion during the ICU stay. In 13 patients, how-
ever, the age of RBC units could not be confirmed and
they were excluded from the analysis leaving 652 patients
(36.6%) in the transfused patient population. During ICU
treatment, the transfused patients received 3 (2 to 6) units
of RBCs. The patient characteristics according to transfu-
sion status are presented in Additional file 1: Table S1.
The median (IQR) age of all RBC units transfused was 14
(11–19) days and the median age of the oldest RBC unit
transfused was 18 (14 to 25) days. Of all 3,325 transfu-
sions, 2,334 (70.2%) were given during the first 72 hours
of ICU treatment, and the median time from ICU admis-
sion to the administration of the oldest RBC unit was 22
(0.2 to 70.0) hours. The times for ICU admission, AKI and
RBC transfusions are presented in Additional file 1: Table
S2. The patient characteristics according to the quartiles
of the oldest RBCs are presented in Table 1.
The incidence of different stages of AKI and adminis-
tration of RRT, according to quartiles of the oldest RBC
unit, are presented in Table 2. In the logistic regression





SAPS II score without points for age and renal componenents, points
Pre-ICU colloids
Pre-ICU hypovolemia
RBC, Q2 to Q4 versus Q1
Units transfused pre-AKI, number
In total, 404 patients were included in the model. Hosmer-Lemeshow Chi-square 9.
Q4 denotes the second to the fourth quartile. SAPS II, simplified acute physiology scomponents) and number of RBCs transfused prior to
AKI were independent risk factors for KDIGO stage 3
AKI (Table 3). The number of patients with renal non-
recovery was inadequate for analysis as a dependent
variable by logistic regression (Table 4).
The ICU length of stay, renal non-recovery, hospital
and 90-day mortality rates are presented in Table 4. On
logistic regression, patients in RBC age quartiles 2 to 4
had increased risk of hospital mortality compared to
patients in the freshest quartile. Age, SAPS II without
age points and maximum SOFA score were also associ-
ated with increased risk of hospital mortality (Additional
file 1: Table S3). In a separate model for 90-day mortal-
ity, age, number of transfused units, SAPS II without
age points and maximum SOFA score were significant
predictors, whereas the age of RBCs was not (Table 5).
The hazard ratios from Cox regression analysis are
presented in Additional file 1: Table S4. The hospital and
90-day mortality rates in transfused patients according to
quartiles of the oldest transfused RBCs are presented in
Figures 1 and 2.
Discussion
In this large, observational multicenter study, we found
that transfusion of older RBCs was independently associ-
ated with an increased risk of hospital mortality, but not
90-day mortality, or the development of KDIGO stage 3
AKI. The number of transfused RBC units, however, was
independently associated with 90-day mortality.
Evidence on the impact of storage lesions of RBCs in
critically ill patients is accumulating. The evidence for a
deleterious effect arises mostly from observational stud-
ies. The only large RCT has been conducted in prema-
ture infants, and in this patient group, there was no
morbidity or mortality benefit of fresher (less than 7
days) RBC transfusion compared to standard care [11].
The RCTs including adult patients have been smaller,
with only 17 to 100 patients, aiming to test the feasibility
of study logistics, or with surrogate variables as study
endpoints [8-10,18]. Large RCTs are underway, but thelysis of KDIGO stage 3 acute kidney injury
Odds ratio 95% CI lower 95% CI upper P-value
1.005 0.984 1.026 0.628
0.586 0.306 1.124 0.108
1.924 0.737 5.021 0.181
1.060 1.037 1.084 <0.001
1.134 0.615 2.093 0.686
1.177 0.625 2.219 0.613
1.066 0.507 2.238 0.867
1.076 1.019 1.135 0.008
390 P = 0.310. Q1 denotes the first and freshest oldest RBC unit quartile, Q2 to
core, RBC, red blood cell; AKI, acute kidney injury.
Table 4 Patient outcomes (quartiles according to the
oldest red blood cells transfused)
Quartile 1 Quartiles 2 to 4 P-
value(n = 143) (n = 509)
ICU length of stay, days 2.8 (1.6, 4.8) 4.2 (1.9, 8.7) <0.001
Renal non-recovery† 1.4% (0.4, 5.0) 1.2% (0.5, 2.6) 0.689
Hospital mortality 10.5% (5.5, 15.5) 20.8% (17.3, 24.4) 0.005
90-day mortality 20.3% (13.7, 26.9) 29.9% (25.9, 33.8) 0.026
The results are presented as median and IQR or as percentage with 95%
confidence interval. Renal non-recovery is defined as dialysis dependence at
90 days.
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leaving clinicians uncertain with regard to the import-
ance of age of RBCs.
RBC transfusions have also been associated with an in-
creased risk of renal failure [21]. Transfusion of older
RBCs has been associated with increased risk of renal
failure in some studies [22,23], whereas in others no in-
dependent association of RBC age with AKI was found
[21]. The power of our study was inadequate to study
the association between age of blood and renal non-
recovery. In the model predicting KDIGO stage 3, only
scores on SAPS II without age points, and number of
RBCs transfused, were independent predictors of AKI,
whereas the age of RBCs was not. The prediction of
KDIGO stage 3 AKI was also relatively inaccurate in this
patient population as the median time from ICU admis-
sion to KDIGO stage 3 AKI was only 26 hours, and ac-
cordingly only a small proportion of RBC’s had been




Propensity score for receiving >14 day-old RBCs 0.083
Transfused units, number 1.057
Acute kidney injury 0.774
Severe sepsis 0.785
RBC age Q2 to Q4 versus Q1 1.448




SAPS II score without age points 1.031
SOFA score, maximum during ICU stay 1.219
Highest lactate 0.997
Female gender 0.785
Included patients 571 (132 in Q1 and 468 in Q2 to Q4). Hosmer-Lemeshow Chi-squ
and chronic health evaluation; DIC, disseminated intravascular coagulopathy; SAPS,Most observational studies on the effects of age of
transfused RBCs on patient morbidity and mortality
have been conducted in trauma and cardiac surgery pa-
tients [7]. Although these patients are often treated in
the ICU, they have lower overall mortality as a group,
and accordingly are not representative of the general
critically ill patient population [24,25]. Of the two obser-
vational studies that have been conducted in unselected
critically ill patients [17,26], one has been published only
as an abstract [26]. In the Australian and New Zealand
Intensive Care Society (ANZICS) study, the results were
in line with our findings, as the hospital mortality in-
creased with increasing age of the oldest RBC unit [17].
The long-term mortality was not, however, reported in
that study. In a meta-analysis combining patients with
various conditions (cardiac surgery, trauma and general
hospitalized patients), transfusion of older RBC units
was associated with increased mortality [7]. The highest
impact on the result comes, however, from a retrospect-
ive study of 387,130 hospitalized patients, reporting
one-week mortality. Critically ill patients represented
less than 1% of the total number of patients in this
meta-analysis [7].
There are several methods of producing RBC units from
donated blood [13,27]. The differences in RBC production
methods have an effect on the degree and magnitude of
storage lesions over time, leading to variations in the
recommended storage times for RBC units [27]. Interest-
ingly, studies conducted in North America consistently re-
port an increased risk of adverse endpoints with increased
RBC storage age [28]. The results of studies conductedysis of 90-day mortality
















are 5.407, P = 0.713. RBC, red blood cell; Q, quartile; APACHE, acute physiology
simplified acute physiology score; SOFA, sequential organ failure assessment.
Figure 1 Crude hospital and 90-day mortality in non-transfused and transfused patients according to quartiles (Q) of the oldest red
blood cell (RBC) unit.
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ences in study results are suggested to be the result of a
different production process leading to differences in stor-
age lesions in RBC units [28].
This is the first study to describe the incidence of AKI
and long-term mortality in critically ill patients trans-
fused with RBCs of varying storage times. In our study,
AKI was described by the latest recommended stagingFigure 2 Kaplan-Meier curve (adjusted for baseline variables) for non
the oldest red blood cell (RBC) unit.by KDIGO [15]. As presented in Table 2, there were seem-
ingly more AKI and more stage 3 AKI in patients in the
RBC age quartiles 2 to 4. However, when appropriate ad-
justments in multivariable analysis were performed, the
age of transfused RBCs was not associated with the devel-
opment of AKI stage 3. This implies that the incidence of
KDIGO stage 3 AKI is not increased by transfusion of
older RBCs. Hospital and 90-day crude mortality rates-transfused and transfused patients according to quartiles (Q) of
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versus quartiles 2 to 4. Here again, the adjustment for
other variables showed that the transfusion of fresher
RBCs was associated with hospital mortality but not 90-
day mortality. The association between transfusion of aged
RBCs and hospital mortality has been shown previously,
but this is the first study to investigate the association with
long-term mortality.
In non-randomized studies, there are frequently base-
line differences between patient populations. In baseline
variables, there are many differences in patient charac-
teristics across quartiles of RBC age with increasing
severity towards Q4. Previously, increased number of
RBC transfusions has been associated with both sicker
patients and increased risk of having older RBCs [29].
Adjusting for these differences in multivariable analysis
translates findings more reliably, however, there is still
room for residual confounders. This underlines the
need for an RCT with sufficient power and clinically
relevant endpoints to either confirm or refute the pos-
sible negative effects of older RBCs transfused to critic-
ally ill patients.
Our study has some limitations. First, the RBC data
prior to ICU admission was not available, except for the
information on massive blood transfusions (>10 units of
RBCs in 24 hours) prior to admission. As individual
RBC-unit information was not available, the age of RBCs
in these pre-ICU transfusions remains unknown. Sec-
ond, we did not collect the information on the use of
other blood products, as the primary study was targeted
to evaluate the incidence and prognosis of AKI in critic-
ally ill patients. Third, renal non-recovery was rare, and
accordingly, the study was not powered to evaluate the
possible associations of risk factors with poor renal re-
covery. Fourth, due to the observational design of this
study, the transfused patients were different between
quartiles of oldest RBCs transfused and those who were
transfused versus non-transfused. In the analysis without
adjustment for baseline differences, there was an in-
crease in the incidence of AKI, and hospital and 90-day
mortality (Tables 2 and 4). However, when adjusted for
the baseline differences in multivariable analysis, the age
of the oldest RBC unit was independently associated
with hospital mortality only, but not with KDIGO stage
3 AKI or 90-day mortality. As we could adjust only for
the variables that were collected in the study, residual
confounders cannot be excluded.
Conclusions
In this prospective observational study we were able to
confirm the independent association between transfu-
sion of older RBCs and increased risk of hospital mortal-
ity, but did not detect an independent association with
90-day mortality or the development of KDIGO stage 3AKI. However, the number of transfused RBC units was
an independent predictor of 90-day mortality in unse-
lected critically ill patients. A large-scale multicenter
RCT is needed to evaluate the possible negative effect of
older RBCs in critically ill patients.
Key messages
 36.6% of critically ill patients were transfused during
the ICU stay.
 Transfused patients received a median of 3 units
(IQR 2 to 6) of RBCs.
 70.2% of all transfusions were given within 72 hours
of ICU admission.
 The age of transfused RBCs was independently
associated with hospital mortality but not with
90-day mortality or KDIGO stage 3 AKI.
 The number of transfused RBCs was an independent
risk factor for 90-day mortality.
Additional file
Additional file 1: Table S1. Characteristics of non-transfused and
transfused patients. Table S2: Times for ICU admission and AKI (acute
kidney injury). Table S3: Odds ratios with 95% CI from logistic regression
analysis of hospital mortality. Table S4: Cox regression analysis for 90-day
mortality (enter method).
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